Cruiser Capital Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Cruiser Capital Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell
2018 Q3	$301K	Buy
2018 Q2	$320K	Sell
2018 Q1	$341K	Hold
2017 Q4	$492K	Buy